Singapore markets closed
Straits Times Index
3,367.90 +29.33 (+0.88%) S&P 500
5,475.09 +14.61 (+0.27%) Dow
39,169.52 +50.66 (+0.13%) Nasdaq
17,879.30 +146.70 (+0.83%) Bitcoin USD
62,816.80 +35.67 (+0.06%) CMC Crypto 200
1,343.36 -1.15 (-0.09%)
Evoke Pharma, Inc. (EVOK)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 0.5290 |
| Open | 0.5289 |
| Bid | 0.3500 x 200 |
| Ask | 0.6630 x 200 |
| Day's range | 0.4718 - 0.5289 |
| 52-week range | 0.4000 - 1.7700 |
| Volume | |
| Avg. volume | 27,598 |
| Market cap | 4.056M |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
We feel now is a pretty good time to analyse Evoke Pharma, Inc.'s ( NASDAQ:EVOK ) business as it appears the company...
- Insider Monkey
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript March 14, 2024 Evoke Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.5. Evoke Pharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, […]
- Thomson Reuters StreetEvents
Q4 2023 Evoke Pharma Inc Earnings Call
Q4 2023 Evoke Pharma Inc Earnings Call
© 2024 Yahoo. All rights reserved.